APO RESEARCH · REPORT
Paclitaxel Injection
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Product & engineering
Understand the product.
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
Selected research
Industry Research
Paclitaxel Injection Industry Research Report 2026
Market perspective
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Read the full market overview
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.
Report Scope
This report quantifies the global Paclitaxel Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Paclitaxel Injection Market by Company
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
Paclitaxel Injection Segment by Type
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg
Paclitaxel Injection Segment by Application
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other
Paclitaxel Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Paclitaxel Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Paclitaxel Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Paclitaxel Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5ml,30mg
- 10ml,60mg
- 16.7ml,100mg
- 25ml,150mg
- 50ml,300mg
Applications
- Ovarian Cancer
- Breast Cancer
- Cervical Cancer
- Pancreatic Cancer
- Other
Companies covered
- Bristol-Myers Squibb
- Celgene Corporation
- Hospira
- Biological E.
- Taj Accura
- Khandelwal Laboratories
- Luye Pharma
- Beijing Youcare
- Beijing Union
- Haiyao
- Chuntch
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Paclitaxel Injection Market Size (2021-2032)
- 2.2.2 Global Paclitaxel Injection Sales (2021-2032)
- 2.2.3 Global Paclitaxel Injection Market Average Price (2021-2032)
- 2.3 Paclitaxel Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5ml,30mg
- 2.3.3 10ml,60mg
- 2.3.4 16.7ml,100mg
- 2.3.5 25ml,150mg
- 2.3.6 50ml,300mg
- 2.4 Paclitaxel Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ovarian Cancer
- 2.4.3 Breast Cancer
- 2.4.4 Cervical Cancer
- 2.4.5 Pancreatic Cancer
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Paclitaxel Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Paclitaxel Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Paclitaxel Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Paclitaxel Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Paclitaxel Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Paclitaxel Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Paclitaxel Injection, Product Type & Application
- 3.8 Global Manufacturers of Paclitaxel Injection, Established Date
- 3.9 Global Paclitaxel Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bristol-Myers Squibb
- 4.1.1 Bristol-Myers Squibb Company Information
- 4.1.2 Bristol-Myers Squibb Business Overview
- 4.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Portfolio
- 4.1.5 Bristol-Myers Squibb Recent Developments
- 4.2 Celgene Corporation
- 4.2.1 Celgene Corporation Company Information
- 4.2.2 Celgene Corporation Business Overview
- 4.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Celgene Corporation Paclitaxel Injection Product Portfolio
- 4.2.5 Celgene Corporation Recent Developments
- 4.3 Hospira
- 4.3.1 Hospira Company Information
- 4.3.2 Hospira Business Overview
- 4.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hospira Paclitaxel Injection Product Portfolio
- 4.3.5 Hospira Recent Developments
- 4.4 Biological E.
- 4.4.1 Biological E. Company Information
- 4.4.2 Biological E. Business Overview
- 4.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biological E. Paclitaxel Injection Product Portfolio
- 4.4.5 Biological E. Recent Developments
- 4.5 Taj Accura
- 4.5.1 Taj Accura Company Information
- 4.5.2 Taj Accura Business Overview
- 4.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taj Accura Paclitaxel Injection Product Portfolio
- 4.5.5 Taj Accura Recent Developments
- 4.6 Khandelwal Laboratories
- 4.6.1 Khandelwal Laboratories Company Information
- 4.6.2 Khandelwal Laboratories Business Overview
- 4.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Khandelwal Laboratories Paclitaxel Injection Product Portfolio
- 4.6.5 Khandelwal Laboratories Recent Developments
- 4.7 Luye Pharma
- 4.7.1 Luye Pharma Company Information
- 4.7.2 Luye Pharma Business Overview
- 4.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Luye Pharma Paclitaxel Injection Product Portfolio
- 4.7.5 Luye Pharma Recent Developments
- 4.8 Beijing Youcare
- 4.8.1 Beijing Youcare Company Information
- 4.8.2 Beijing Youcare Business Overview
- 4.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beijing Youcare Paclitaxel Injection Product Portfolio
- 4.8.5 Beijing Youcare Recent Developments
- 4.9 Beijing Union
- 4.9.1 Beijing Union Company Information
- 4.9.2 Beijing Union Business Overview
- 4.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Beijing Union Paclitaxel Injection Product Portfolio
- 4.9.5 Beijing Union Recent Developments
- 4.10 Haiyao
- 4.10.1 Haiyao Company Information
- 4.10.2 Haiyao Business Overview
- 4.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Haiyao Paclitaxel Injection Product Portfolio
- 4.10.5 Haiyao Recent Developments
- 4.11 Chuntch
- 4.11.1 Chuntch Company Information
- 4.11.2 Chuntch Business Overview
- 4.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Chuntch Paclitaxel Injection Product Portfolio
- 4.11.5 Chuntch Recent Developments
5 Global Paclitaxel Injection Market Scenario by Region
- 5.1 Global Paclitaxel Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Paclitaxel Injection Sales by Region: 2021-2032
- 5.2.1 Global Paclitaxel Injection Sales by Region: 2021-2026
- 5.2.2 Global Paclitaxel Injection Sales by Region: 2027-2032
- 5.3 Global Paclitaxel Injection Revenue by Region: 2021-2032
- 5.3.1 Global Paclitaxel Injection Revenue by Region: 2021-2026
- 5.3.2 Global Paclitaxel Injection Revenue by Region: 2027-2032
- 5.4 North America Paclitaxel Injection Market Facts & Figures by Country
- 5.4.1 North America Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Paclitaxel Injection Sales by Country (2021-2032)
- 5.4.3 North America Paclitaxel Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Paclitaxel Injection Market Facts & Figures by Country
- 5.5.1 Europe Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Paclitaxel Injection Sales by Country (2021-2032)
- 5.5.3 Europe Paclitaxel Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Paclitaxel Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Paclitaxel Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Paclitaxel Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Paclitaxel Injection Market Facts & Figures by Country
- 5.7.1 South America Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Paclitaxel Injection Sales by Country (2021-2032)
- 5.7.3 South America Paclitaxel Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Paclitaxel Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Paclitaxel Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Paclitaxel Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Paclitaxel Injection Sales by Type (2021-2032)
- 6.1.1 Global Paclitaxel Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Paclitaxel Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Paclitaxel Injection Revenue by Type (2021-2032)
- 6.2.1 Global Paclitaxel Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Paclitaxel Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Paclitaxel Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Paclitaxel Injection Sales by Application (2021-2032)
- 7.1.1 Global Paclitaxel Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Paclitaxel Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Paclitaxel Injection Revenue by Application (2021-2032)
- 7.2.1 Global Paclitaxel Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Paclitaxel Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Paclitaxel Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Paclitaxel Injection Value Chain Analysis
- 8.1.1 Paclitaxel Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Paclitaxel Injection Production Mode & Process
- 8.2 Paclitaxel Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Paclitaxel Injection Distributors
- 8.2.3 Paclitaxel Injection Customers
9 Global Paclitaxel Injection Analyzing Market Dynamics
- 9.1 Paclitaxel Injection Industry Trends
- 9.2 Paclitaxel Injection Industry Drivers
- 9.3 Paclitaxel Injection Industry Opportunities and Challenges
- 9.4 Paclitaxel Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst